List

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY19 is not expected to be complete until April, 2020.

  1. A STANDARD REPOSITORY FOR HUMAN GENE MAPPING

    SBC: Genaissance Pharmaceuticals            Topic: N/A

    N/A

    SBIR Phase I 1985 Department of Health and Human Services
  2. AS A FUNCTION OF ETHYLENE OXIDE STERILIZATION AND STORAGE TIME.

    SBC: BOSTON BIOTECHNOLOGY CORPORATION            Topic: N/A

    AS A FUNCTION OF ETHYLENE OXIDE STERILIZATION AND STORAGE TIME.PRIMARY BILIARY CIRRHOSIS (PBC) IS A DEGENERATIVE LIVER DISEASE OF UNKNOWN ETIOLOGY WHICH FREQUENTLY RESULTS IN DEATH WITHIN 5 TO 10 YEARS OF THE ONSET OF SYMPTOMS. LABORATORY DIAGNOSIS OF PBC IS CURRENTLY BASED UPON HISTOLOGICAL FINDINGS IN BIOPSY MATERIAL AND DETECTION OF SERUM ANTIMITOCHONDRIAL ANTIBODIES (AMA) BY IMMUNOFLUORESCENT ...

    SBIR Phase I 1985 Department of Health and Human Services
  3. CALCULI, OR STONES, IN THE URINARY TRACT IS A RECURRING PROBLEM, AFFECTING NEARLY 800,000 IN THE U.

    SBC: CANDELA CORPORATION            Topic: N/A

    CALCULI, OR STONES, IN THE URINARY TRACT IS A RECURRING PROBLEM, AFFECTING NEARLY 800,000 IN THE U.S. ANNUALLY. INCISIONS TO REMOVE URINARY CALCULI ARE HIGHLY TRAUMATIC, CREATING TISSUE DAMAGE, PAIN, AND POSTOPERATIVE DISCOMFORT. RECENT ADVANCES IN TECHNOLOGY REDUCE TRAUMA BY MINIMIZING THE NEED FOR SURGERY. LASER LITHOTRIPSY HAS IMMENSE APPEAL, BUT A USEFUL DEVICE HAS NOT BEEN AVAILABLE. THE MASS ...

    SBIR Phase I 1985 Department of Health and Human Services
  4. SPECIFIC AIMS: WE HAVE RAISED A POTENT MONOCLONAL ANTIBODY (RBC-A) AGAINST BLOOD GROUP A ANTIGEN.

    SBC: CBR LABORATORIES, INC.            Topic: N/A

    SPECIFIC AIMS: WE HAVE RAISED A POTENT MONOCLONAL ANTIBODY (RBC-A) AGAINST BLOOD GROUP A ANTIGEN. OUR AIMS ARE TO: 1. RAISE ADDITIONAL MONOCLONAL ANTIBODIES TO RED BLOOD CELL ALLOANTIGENS; 2. INSTITUTE THE TECHNOLOGY FOR THE PRODUCTION OF HUMAN 3. COMPLETE THE STUDY ON THE COMMERCIAL VALUE OF OUR MONOCLONAL RBC-A AS AN EFFECTIVE IN VITRO DIAGNOSTIC REAGENT. LONG-TERM OBJECTIVES TO HEALTH RELATEDNE ...

    SBIR Phase I 1985 Department of Health and Human Services
  5. TESTING ITS IMMUNOTHERAPEUTIC POTENTIAL THE LONG-TERM OBJECTIVE OF THIS PROJECT IS TO DEVELOP PROCESSES FOR THE PRODUCTION OF B-CELL GROWTH FACTOR (BCGF) AND TO TEST THE POTENTIAL APPLICATIONS OF BCGF FOR THE TREATMENT OF HUMAN IMMUNOPATHOLOGICAL

    SBC: C-MOTION, INC.            Topic: N/A

    TESTING ITS IMMUNOTHERAPEUTIC POTENTIAL THE LONG-TERM OBJECTIVE OF THIS PROJECT IS TO DEVELOP PROCESSES FOR THE PRODUCTION OF B-CELL GROWTH FACTOR (BCGF) AND TO TEST THE POTENTIAL APPLICATIONS OF BCGF FOR THE TREATMENT OF HUMAN IMMUNOPATHOLOGICAL CONDITIONS. BCGF MAY BE USEFUL AS AN IMMUNOTHERAPEUTIC AGENT IN THE TREATMENT OF PRIMARY IMMUNODEFICIENCY DISEASES AND POSSIBLY IN CERTAIN B-CELL LEUKEMI ...

    SBIR Phase I 1985 Department of Health and Human Services
  6. THE OBJECTIVE OF THIS RESEARCH PLAN IS TO ISOLATE A CDNA SEQUENCE ENCODING TUMOR NECROSIS FACTOR (TNF) AND, BY MANIPULATION OF THAT SEQUENCE, TO PRODUCE AND SECRETE THE MATURE TNF PROTEIN FROM THE YEAST SACCHAROMYCES CEREVISIAE.

    SBC: C-MOTION, INC.            Topic: N/A

    THE OBJECTIVE OF THIS RESEARCH PLAN IS TO ISOLATE A CDNA SEQUENCE ENCODING TUMOR NECROSIS FACTOR (TNF) AND, BY MANIPULATION OF THAT SEQUENCE, TO PRODUCE AND SECRETE THE MATURE TNF PROTEIN FROM THE YEAST SACCHAROMYCES CEREVISIAE. PREVIOUS WORK ON TNF HAS SHOWN IT TO HAVE CYTOSTATIC OR CYTOLYTIC ACTIVITY IN VITRO AGAINST A NUMBER OF TRANSFORMED CELL LINES AND TO HAVE TUMOR NECROTIC ACTIVITY AGAINST ...

    SBIR Phase I 1985 Department of Health and Human Services
  7. LYMPHOTOXIN IS A LYMPHOKINE WHICH HAS POTENT ANTITUMOR ACTIVITY.

    SBC: C-MOTION, INC.            Topic: N/A

    LYMPHOTOXIN IS A LYMPHOKINE WHICH HAS POTENT ANTITUMOR ACTIVITY. IT IS A GLYCOPROTEIN WITH A MOLECULAR WEIGHT OF 25,000 DALTONS. DUE TO THE MINUTE AMOUNT PRODUCED BY LYMPHOCYTES, EVALUATION OF ITS PHARMACEUTICAL POTENTIAL REQUIRES THAT IT BE CLONED AND EXPRESSED IN A SUITABLE HOST. IN ORDER TO OBTAIN THE CORRECT GLYCOSYLATION PATTERN, WE PROPOSE TO EXPRESS IT IN MAMMALIAN CELLS. IN PHASE I, WE PLA ...

    SBIR Phase I 1985 Department of Health and Human Services
  8. WE PROMISE TO DEVELOP METHODS FOR THE LARGE-SCALE PRODUCTION OF HUMAN COLONY STIMULATING FACTORS (CSF) FROM NORMAL HUMAN PERIPHERAL BLOOD LYMPHOCYTES.

    SBC: C-MOTION, INC.            Topic: N/A

    WE PROMISE TO DEVELOP METHODS FOR THE LARGE-SCALE PRODUCTION OF HUMAN COLONY STIMULATING FACTORS (CSF) FROM NORMAL HUMAN PERIPHERAL BLOOD LYMPHOCYTES. THE FERMENTATION METHODS EMPLOYED WILL BE SIMILAR TO THOSE USED FOR THE PRODUCTION OF NATURAL INTERLEUKIN-2. WE ARE PRODUCING HUMAN IL-2 FOR CLINICAL EVALUATION BY THE BIOLOGICAL RESPONSE MODIFIERS PROGRAM (BRMP). PURIFIED CSFS WILL BE TESTED IN PRE ...

    SBIR Phase I 1985 Department of Health and Human Services
  9. WE PROPOSE TO DEVELOP A METHODOLOGY BY WHICH THE GENES CODING FOR AUTOIMMUNE DISEASE-SPECIFIC PROTEIN ANTIGENS CAN BE RAPIDLY CLONED USING RECOMBINANT DNA TECHNIQUES.

    SBC: C-MOTION, INC.            Topic: N/A

    WE PROPOSE TO DEVELOP A METHODOLOGY BY WHICH THE GENES CODING FOR AUTOIMMUNE DISEASE-SPECIFIC PROTEIN ANTIGENS CAN BE RAPIDLY CLONED USING RECOMBINANT DNA TECHNIQUES. THE SYSTEM WHICH WE ARE USING LENDS ITSELF TO HIGH-LEVEL EXPRESSION OF THESE ANTIGENS AS HYBRID PROTEINS IN E. COLI. THIS FACILITATES PRODUCTION OF THESE ANTIGENS FOR IN PHASE I A CDNA LIBRARY WILL BE CONSTRUCTED FROM HUMAN THYROID T ...

    SBIR Phase I 1985 Department of Health and Human Services
  10. WE PROPOSE TO IDENTIFY THE GENES FOR AUTOIMMUNE DISEASE-SPECIFIC PROTEIN ANTIGENS BY THE USE OF RECOMBINANT DNA TECHNIQUES.

    SBC: C-MOTION, INC.            Topic: N/A

    WE PROPOSE TO IDENTIFY THE GENES FOR AUTOIMMUNE DISEASE-SPECIFIC PROTEIN ANTIGENS BY THE USE OF RECOMBINANT DNA TECHNIQUES. THE SYSTEM THAT WE ARE USING LENDS ITSELF TO HIGH-LEVEL EXPRESSION OF THESE ANTIGENS AS HYBRID PROTEINS IN E. COLI. THIS APPROACH FACILITATES PRODUCTION OF THESE ANTIGENS FOR THE PURPOSE OF ANTIGEN CHARACTERIZATION, GENERATION OF ANTIBODIES AND DEVELOPMENT OF IMMUNODIAGNOSTIC ...

    SBIR Phase I 1985 Department of Health and Human Services

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government